Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 25

    1.

    Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.

    van der Linden MW, Plat AW, Erkens JA, Emneus M, Herings RM.

    Value Health. 2009 Sep;12(6):909-14. Epub 2009 Mar 11.PMID: 19508664 [PubMed - indexed for MEDLINE]Related articles

    2.

    Effect of non-persistent use of oral glucose-lowering drugs on HbA1c goal attainment.

    Penning-van Beest FJ, van der Bij S, Erkens JA, Kessabi S, Groot M, Herings RM.

    Curr Med Res Opin. 2008 Sep;24(9):2523-9.PMID: 18812016 [PubMed - indexed for MEDLINE]Related articles

    3.

    Determinants of non-compliance with bisphosphonates in women with postmenopausal osteoporosis.

    Penning-van Beest FJ, Erkens JA, Olson M, Herings RM.

    Curr Med Res Opin. 2008 May;24(5):1337-44. Epub 2008 Mar 31.PMID: 18380910 [PubMed - indexed for MEDLINE]Related articles

    4.

    Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO study.

    Breekveldt-Postma NS, Erkens JA, Aalbers R, van de Ven MJ, Lammers JW, Herings RM.

    Curr Med Res Opin. 2008 Apr;24(4):975-83. Epub 2008 Feb 15.PMID: 18282372 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment with inhaled corticosteroids in asthma is too often discontinued.

    Breekveldt-Postma NS, Koerselman J, Erkens JA, van der Molen T, Lammers JW, Herings RM; CAMERA Study GroupMembers listed in the Appendix.

    Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):411-22.PMID: 18205251 [PubMed - indexed for MEDLINE]Related articles

    6.

    Higher persistence with valsartan compared with enalapril in daily practice.

    Siiskonen SJ, Breekveldt-Postma NS, Vincze G, Khan ZM, Erkens JA, Herings RM.

    Vasc Health Risk Manag. 2007;3(6):1039-44.PMID: 18200822 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice.

    Sukel MP, Breekveldt-Postma NS, Erkens JA, van der Linden PD, Beiderbeck AB, Coebergh JW, Herings RM.

    Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):125-34.PMID: 18058835 [PubMed - indexed for MEDLINE]Related articles

    8.

    Medicinal cannabis in oncology.

    Engels FK, de Jong FA, Mathijssen RH, Erkens JA, Herings RM, Verweij J.

    Eur J Cancer. 2007 Dec;43(18):2638-44. Epub 2007 Oct 31. Review.PMID: 17976975 [PubMed - indexed for MEDLINE]Related articles

    9.

    Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.

    Sukel MP, van der Linden MW, Chen C, Erkens JA, Herings RM.

    Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):9-19.PMID: 17963198 [PubMed - indexed for MEDLINE]Related articles

    10.

    Loss of treatment benefit due to low compliance with bisphosphonate therapy.

    Penning-van Beest FJ, Erkens JA, Olson M, Herings RM.

    Osteoporos Int. 2008 Apr;19(4):511-7. Epub 2007 Sep 14.PMID: 17874028 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

    Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ.

    Am J Psychiatry. 2007 Sep;164(9):1356-63.PMID: 17728420 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.

    Breekveldt-Postma NS, Koerselman J, Erkens JA, Lammers JW, Herings RM.

    Respir Med. 2007 Jul;101(7):1398-405. Epub 2007 Mar 23.PMID: 17368011 [PubMed - indexed for MEDLINE]Related articles

    13.

    Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.

    Penning-van Beest FJ, Goettsch WG, Erkens JA, Herings RM.

    Clin Ther. 2006 Feb;28(2):236-42.PMID: 16678644 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.

    Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM.

    Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):795-803.PMID: 16178043 [PubMed - indexed for MEDLINE]Related articles

    15.

    Limited use of medicinal cannabis but for labeled indications after legalization.

    Erkens JA, Janse AF, Herings RM.

    Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):821-2.PMID: 16149121 [PubMed - indexed for MEDLINE]Related articles

    16.

    Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice.

    Spoelstra JA, Stolk RP, Klungel OH, Erkens JA, Rutten GE, Leufkens HG, Grobbee DE.

    Diabet Med. 2004 Aug;21(8):896-900.PMID: 15270794 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus.

    Spoelstra JA, Stolk RP, Cohen D, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.

    J Clin Psychiatry. 2004 May;65(5):674-8.PMID: 15163254 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients.

    Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

    Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):139-46.PMID: 15072112 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased suicide attempt rate among patients interrupting use of atypical antipsychotics.

    Herings RM, Erkens JA.

    Pharmacoepidemiol Drug Saf. 2003 Jul-Aug;12(5):423-4.PMID: 12899119 [PubMed - indexed for MEDLINE]Related articles

    20.

    Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery.

    Souverein PC, Erkens JA, de la Rosette JJ, Leufkens HG, Herings RM.

    Eur Urol. 2003 May;43(5):528-34.PMID: 12705998 [PubMed - indexed for MEDLINE]Related articles

    21.

    Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

    Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE.

    Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):121-7.PMID: 12642975 [PubMed - indexed for MEDLINE]Related articles

    22.

    Factors associated with switching from oral hypoglycaemic agents to insulin therapy.

    Spoelstra JA, Stol RP, de Bruyne MC, Erkens JA, Herings RM, Leufkens HG, Grobbee DE.

    Neth J Med. 2002 Jul;60(6):243-8.PMID: 12365467 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients.

    Erkens JA, Klungel OH, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

    Eur Heart J. 2002 Oct;23(20):1575-9.PMID: 12323156 [PubMed - indexed for MEDLINE]Related articles

    24.

    Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus.

    Erkens JA, Herings RM, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

    J Clin Epidemiol. 2002 Apr;55(4):345-9.PMID: 11927201 [PubMed - indexed for MEDLINE]Related articles

    25.

    Cardiovascular drug use and hospitalizations attributable to type 2 diabetes.

    Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG.

    Diabetes Care. 2001 Aug;24(8):1428-32.PMID: 11473081 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...